Literature DB >> 26053710

Assessing Cutaneous Psoriasis Activity Using FDG-PET: Nonattenuation Corrected Versus Attenuation Corrected PET Images.

Anshika Bakshi1, Saeid Gholami, Abass Alavi, Joel M Gelfand, Junko Takeshita.   

Abstract

Psoriasis is a chronic inflammatory skin condition characterized by well-circumscribed erythematous plaques with thick silvery scale. Infiltration of inflammatory cells such as lymphocytes, neutrophils, and macrophages and epidermal cell proliferation within psoriatic lesions may result in selective FDG accumulation. We present a 55-year-old patient with a 30-year history of psoriasis. Nonattenuation corrected PET/CT images demonstrated significant cutaneous FDG uptake corresponding to clinically apparent psoriatic lesions. However, in attenuation corrected (AC) FDG-PET images, the signal was substantially diminished and minimally detectable. Nonattenuation corrected FDG-PET images may be useful and preferable to AC images in assessing skin inflammation in psoriasis.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26053710      PMCID: PMC4589162          DOI: 10.1097/RLU.0000000000000851

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  17 in total

1.  Increased FDG uptake along dermatome on PET in a patient with herpes zoster.

Authors:  Charles Egan; Eugene Silverman
Journal:  Clin Nucl Med       Date:  2013-09       Impact factor: 7.794

2.  Lesion-to-background ratio in nonattenuation-corrected whole-body FDG PET images.

Authors:  M B Imran; K Kubota; S Yamada; H Fukuda; K Yamada; T Fujiwara; M Itoh
Journal:  J Nucl Med       Date:  1998-07       Impact factor: 10.057

3.  18F-FDG imaging of a rare cutaneous infection by Mycobacterium avium complex.

Authors:  Zhemin Huang; Chun Qiu; Yihui Guan
Journal:  Clin Nucl Med       Date:  2014-03       Impact factor: 7.794

4.  Effect of attenuation correction on lesion detectability in FDG PET of breast cancer.

Authors:  C Bleckmann; J Dose; K H Bohuslavizki; R Buchert; S Klutmann; J Mester; F Jänicke; M Clausen
Journal:  J Nucl Med       Date:  1999-12       Impact factor: 10.057

5.  The contribution of ¹⁸F-FDG PET/CT in a patient with cutaneous metastases of squamous cell carcinoma of the penis.

Authors:  J Banzo; M A Ubieto; A Andrés; L Tardín; E F Rambalde; L F Cancer; P Razola; E Prats
Journal:  Rev Esp Med Nucl Imagen Mol       Date:  2014-05-25       Impact factor: 1.359

Review 6.  The psoriasis area and severity index is the adequate criterion to define severity in chronic plaque-type psoriasis.

Authors:  Jochen Schmitt; Gottfried Wozel
Journal:  Dermatology       Date:  2005       Impact factor: 5.366

7.  Melanoma patients evaluated by four different positron emission tomography reconstruction techniques.

Authors:  D S Schauwecker; A R Siddiqui; J D Wagner; D Davidson; S-H Jung; K A Carlson; G D Hutchins
Journal:  Nucl Med Commun       Date:  2003-03       Impact factor: 1.690

8.  Positron emission tomography revealed diffuse involvement of the lower legs and occult extracutaneous lesions in subcutaneous panniculitis-like T-cell lymphoma.

Authors:  Kenjiro Mitsuhashi; Mitsuru Momose; Akihiro Masuda; Yuichiro Tsunemi; Toshiko Motoji
Journal:  Clin Nucl Med       Date:  2013-03       Impact factor: 7.794

9.  A 50% reduction in the Psoriasis Area and Severity Index (PASI 50) is a clinically significant endpoint in the assessment of psoriasis.

Authors:  Christopher S Carlin; Steven R Feldman; James G Krueger; Alan Menter; Gerald G Krueger
Journal:  J Am Acad Dermatol       Date:  2004-06       Impact factor: 11.527

Review 10.  Positron emission tomography imaging in nonmalignant thoracic disorders.

Authors:  Abass Alavi; Naresh Gupta; Jean-Louis Alberini; Marc Hickeson; Lars-Eric Adam; Peeyush Bhargava; Hongming Zhuang
Journal:  Semin Nucl Med       Date:  2002-10       Impact factor: 4.446

View more
  1 in total

1.  Physiological skin FDG uptake: A quantitative and regional distribution assessment using PET/MRI.

Authors:  Munenobu Nogami; Feibi Zeng; Junko Inukai; Yoshiaki Watanabe; Mizuho Nishio; Tomonori Kanda; Yoshiko R Ueno; Keitaro Sofue; Atsushi K Kono; Masatoshi Hori; Akihito Ohnishi; Kazuhiro Kubo; Takako Kurimoto; Takamichi Murakami
Journal:  PLoS One       Date:  2021-03-26       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.